Bone Morphogenetic Proteins: A Realistic Alternative to Bone Grafting for Alveolar Reconstruction

Oral and Maxillofacial Surgery Clinics of North America

Volumn 19, Issue 4, 2007, Pages 535-551

  Wikesjö, Ulf M E ^a   Huang, Yi Hao ^a   Polimeni, Giuseppe ^a   Qahash, Mohammed ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

BONE DEVELOPMENT; BONE REGENERATION; BONE TRANSPLANTATION; DRUG DELIVERY SYSTEM; DRUG EFFECT; HUMAN; METHODOLOGY; ORAL SURGERY; REVIEW; TOOTH IMPLANTATION;

ALVEOLAR RIDGE AUGMENTATION; ALVEOLOPLASTY; BONE MORPHOGENETIC PROTEINS; BONE TRANSPLANTATION; DENTAL IMPLANTATION, ENDOSSEOUS; DRUG DELIVERY SYSTEMS; HUMANS; ORAL SURGICAL PROCEDURES; OSSEOINTEGRATION; OSTEOGENESIS; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 35348882656     PISSN: 10423699     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coms.2007.07.004     Document Type: Review

References (120)

1. Li R.H., and Wozney J.M. Delivering on the promise of bone morphogenetic proteins. Trends Biotechnol 19 (2001) 255-265
2. Schilephake H. Bone growth factors in maxillofacial skeletal reconstruction. Int J Oral Maxillofac Surg 31 (2002) 469-484
3. Urist M.R. Bone: formation by autoinduction. Science 150 (1965) 893-899
4. Urist M.R., and Strates B.S. Bone morphogenetic protein. J Dent Res 50 (1971) S1392-S1406
5. Hötten G.C., Matsumoto T., Kimura M., et al. Recombinant human growth/differentiation factor 5 stimulates mesenchyme aggregation and chondrogenesis responsible for the skeletal development of limbs. Growth Factors 13 (1996) 65-74
6. Sampath T.K., Maliakal J.C., Hauschka P.V., et al. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 267 (1992) 20352-20362
7. Wang E.A., Rosen V., D'Alessandro J.S., et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci U S A 87 (1990) 2220-2224
8. Celeste A.J., Iannazzi J.A., Taylor R.C., et al. Identification of transforming growth factor ß family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci U S A 87 (1990) 9843-9847
9. Özkaynak E., Rueger D.C., Drier E.A., et al. OP-1 cDNA encodes an osteogenic protein in the TGF-ß family. EMBO J 9 (1990) 2085-2093
10. Wozney J.M., Rosen V., Celeste A.J., et al. Novel regulators of bone formation: molecular clones and activities. Science 242 (1988) 1528-1534
11. Urist M.R. The substratum for bone morphogenesis. Symp Soc Dev Biol 4 (1970) 125-163
12. Urist M.R., Huo Y.K., Brownell A.G., et al. Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography. Proc Natl Acad Sci U S A 81 (1984) 371-375
13. Israel D.I., Nove J., Kerns K.M., et al. Expression and characterization of bone morphogenetic protein-2 in Chinese hamster ovary cells. Growth Factors 7 (1992) 139-150
14. Zhao M., Wang H., and Zhou T. Expression of recombinant mature peptide of human bone morphogenetic protein-2 in Escherichia coli and its activity in bone formation. Chin Biochem J 10 (1994) 319-324
15. Mikulski A.J., and Urist M.R. An antigenic antimorphogenic bone hydrophobic glycopeptide (AHG). Prep Biochem 5 (1975) 21-37
16. Tomford W. Transmission of disease through transplantation of musculoskeletal allografts. J Bone Joint Surg Am 77 (1995) 1742-1754
17. Boden S.D. Clinical application of the BMPs. J Bone Joint Surg Am 83 (2001) S161
18. Bostrom M.P., and Camacho N.P. Potential role of bone morphogenetic proteins in fracture healing. Clin Orthop Relat Res 355 (1998) S274-S282
19. Cook S.D. Preclinical and clinical evaluation of osteogenic protein-1 (BMP-7) in bony sites. Orthopedics 22 (1999) 669-671
20. Cook S.D., Barrack R.L., Shimmin A., et al. The use of osteogenic protein-1 in reconstructive surgery of the hip. J Arthroplasty 16 (2001) 88-94
21. Friedlaender G.E., Perry C.R., Cole J.D., et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 83 (2001) S151-S158
22. Friedlaender G.E. OP-1 clinical studies. J Bone Joint Surg Am 83 (2001) S160-S161
23. Kuslich S.D., Ulstrom C.L., Griffith S.L., et al. The Bagby and Kuslich method of lumbar interbody fusion: history, techniques, and 2-year follow-up results of a United States prospective, multicenter trial. Spine 23 (1998) 1267-1279
24. McKay B., and Sandhu H.S. Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications. Spine 27 (2002) S66-S85
25. Spiro R.C., Liu L.-S., Heidaran M.A., et al. Inductive activity of recombinant human growth and differentiation factor-5. Biochem Soc Trans 28 (2000) 362-368
26. Vaccaro A.R., Anderson D.G., and Toth C.A. Recombinant human osteogenic protein-1 (bone morphogenetic protein-7) as an osteoinductive agent in spinal fusion. Spine 27 (2002) S59-S65
27. Valentin-Opran A., Wozney J., Csimma C., et al. Clinical evaluation of recombinant human bone morphogenetic protein-2. Clin Orthop Relat Res 395 (2002) 110-120
28. Boyne P.J. Animal studies of the application of rhBMP-2 in maxillofacial reconstruction. Bone 19 (1996) S83-S92
29. Boyne P.J., Nath R., and Nakamura A. Human recombinant BMP-2 in osseous reconstruction of simulated cleft palate defects. Br J Oral Maxillofac Surg 36 (1998) 84-90
30. Boyne P.J., Nakamura A., and Shabahang S. Evaluation of the long-term effect of function on rhBMP-2 regenerated hemimandibulectomy defects. Br J Oral Maxillofac Surg 37 (1999) 344-352
31. Marukawa E., Asahina I., Oda M., et al. Functional reconstruction of the non-human primate mandible using recombinant human bone morphogenetic protein-2. Int J Oral Maxillofac Surg 31 (2002) 287-295
32. Mayer M., Hollinger J., Ron E., et al. Maxillary alveolar cleft repair in dogs using recombinant human bone morphogenetic protein-2 and a polymer carrier. Plast Reconstr Surg 98 (1996) 247-259
33. Moghadam H.G., Urist M.R., Sandor G.K., et al. Successful mandibular reconstruction using a BMP bioimplant. J Craniofac Surg 12 (2001) 119-127 [discussion: 128]
34. Sailer H.F., and Kolb E. Application of purified bone morphogenetic protein (BMP) preparations in cranio-maxillo-facial surgery: reconstruction in craniofacial malformations and post-traumatic or operative defects of the skull with lyophilized cartilage and BMP. J Craniomaxillofac Surg 22 (1994) 191-199
35. Sheehan J.P., Sheehan J.M., Seeherman H., et al. The safety and utility of recombinant human bone morphogenetic protein-2 for cranial procedures in a nonhuman primate model. J Neurosurg 98 (2003) 125-130
36. Springer I.N., Acil Y., Kuchenbecker S., et al. Bone graft versus BMP-7 in a critical size defect: cranioplasty in a growing infant model. Bone 37 (2005) 563-569
37. Steinberg B., Chiego Jr. D.J., Huizinga P.J., et al. Effect of human bone morphogenetic protein-2 implant on tooth eruption in an experimental design. J Craniofac Surg 10 (1999) 338-341
38. Terheyden H., Jepsen S., and Rueger D.R. Mandibular reconstruction in miniature pigs with prefabricated vascularized bone grafts using recombinant human osteogenic protein-1: a preliminary study. Int J Oral Maxillofac Surg 28 (1999) 461-463
39. Terheyden H., Knak C., Jepsen S., et al. Mandibular reconstruction with a prefabricated vascularized bone graft using recombinant human osteogenic protein-1: an experimental study in miniature pigs. Part I: prefabrication. Int J Oral Maxillofac Surg 30 (2001) 373-379
40. Terheyden H., Warnke P., Dunsche A., et al. Mandibular reconstruction with prefabricated vascularized bone grafts using recombinant human osteogenic protein-1: an experimental study in miniature pigs. Part II: transplantation. Int J Oral Maxillofac Surg 30 (2001) 469-478
41. Terheyden H., Wang H., Warnke P.H., et al. Acceleration of callus maturation using rhOP-1 in mandibular distraction osteogenesis in a rat model. Int J Oral Maxillof Surg 32 (2003) 528-533
42. Terheyden H., Menzel C., Wang H., et al. Prefabrication of vascularized bone grafts using recombinant human osteogenic protein-1. Part 3: dosage of rhOP-1, the use of external and internal scaffolds. Int J Oral Maxillofac Surg 33 (2004) 164-172
43. Toriumi D.M., Kotler H.S., Luxenberg D.P., et al. Mandibular reconstruction with a recombinant bone-inducing factor: functional, histologic, and biomechanical evaluation. Arch Otolaryngol Head Neck Surg 117 (1991) 1101-1112
44. Toriumi D.M., O'Grady K., Horlbeck D.M., et al. Mandibular reconstruction using bone morphogenetic protein 2: long-term follow-up in a canine model. Laryngoscope 109 (1999) 1481-1489
45. Warnke P.H., Springer I.N., Wiltfang J., et al. Growth and transplantation of a custom vascularised bone graft in a man. Lancet 364 (2004) 766-770
46. Warnke P.H., Springer I.N., Acil Y., et al. The mechanical integrity of in vivo engineered heterotopic bone. Biomaterials 27 (2006) 1081-1087
47. Yudell R.M., and Block M.S. Bone gap healing in the dog using recombinant human bone morphogenetic protein-2. J Oral Maxillofac Surg 58 (2000) 761-766
48. Barboza E.P., Leite Duarte M.E., Geolás L., et al. Ridge augmentation following implantation of recombinant human bone morphogenetic protein-2 in the dog. J Periodontol 71 (2000) 488-496
49. Barboza E., Caúla A.L., Caúla F., et al. Effect of recombinant human bone morphogenetic protein-2 in an absorbable collagen sponge with space-providing biomaterials on the augmentation of chronic alveolar ridge defects. J Periodontol 75 (2004) 702-708
50. Bergenholtz G.I., Wikesjö U.M.E., Sorensen R.G., et al. Observations on healing following endodontic surgery in nonhuman primates (Macaca fascicularis): effects of rhBMP-2. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101 (2006) 116-125
51. Howell T.H., Fiorellini J., Jones A., et al. A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation. Int J Periodontics Restorative Dent 17 (1997) 124-139
52. Hunt D.R., Jovanovic S.A., Wikesjö U.M.E., et al. Hyaluronan supports recombinant human bone morphogenetic protein-2 induced bone reconstruction of advanced alveolar ridge defects in dogs: a pilot study. J Periodontol 72 (2001) 651-658
53. Jovanovic S.A., Hunt D.R., Bernard G.W., et al. Bone reconstruction following implantation of rhBMP-2 and guided bone regeneration in canine alveolar ridge defects. Clin Oral Implants Res 18 (2007) 224-230
54. Jung R.E., Glauser R., Schärer P., et al. Effect of rhBMP-2 on guided bone regeneration in humans. Clin Oral Implants Res 14 (2003) 556-568
55. Marukawa E., Asahina I., Oda M., et al. Bone regeneration using recombinant human bone morphogenetic protein-2 (rhBMP-2) in alveolar defects of primate mandibles. Br J Oral Maxillofac Surg 39 (2001) 452-459
56. Miranda D.A.O., Blumenthal N.M., Sorensen R.G., et al. Evaluation of recombinant human bone morphogenetic protein-2 on the repair of alveolar ridge defects in baboons. J Periodontol 76 (2005) 210-220
57. Roldan J.C., Jepsen S., Miller J., et al. Bone formation in the presence of platelet-rich plasma vs. bone morphogenetic protein-7. Bone 34 (2004) 80-90
58. Terheyden H., Jepsen S., Vogeler S., et al. Recombinant human osteogenic protein 1 in the rat mandibular augmentation model: differences in morphology of the newly formed bone are dependent on the type of carrier. Mund Kiefer Gesichtschir 1 (1997) 272-275
59. Wikesjö U.M.E., Sorensen R.G., and Wozney J.M. Augmentation of alveolar bone and dental implant osseointegration: clinical implications of studies with rhBMP-2. A comprehensive review. J Bone Joint Surg Am 83 (2001) S136-S145
60. Boyne P.J., Marx R.E., Nevins M., et al. A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int J Periodontics Restorative Dent 17 (1997) 11-25
61. Boyne P.J., Lilly L.C., Marx R.E., et al. De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation. J Oral Maxillofac Surg 63 (2005) 1693-1707
62. Groeneveld E.H., van den Bergh J.P., Holzmann P., et al. Histomorphometrical analysis of bone formed in human maxillary sinus floor elevations grafted with OP-1 device, demineralized bone matrix or autogenous bone: comparison with non-grafted sites in a series of case reports. Clin Oral Implants Res 10 (1999) 499-509
63. Groenveld H.H., van den Bergh J.P., Holzmann P., et al. Histological observations of a bilateral maxillary sinus floor elevation 6 and 12 months after grafting with osteogenic protein-1 device. J Clin Periodontol 26 (1999) 841-846
64. Hanisch O., Tatakis D.N., Rohrer M.D., et al. Bone formation and osseointegration stimulated by rhBMP-2 following subantral augmentation procedures in nonhuman primates. Int J Oral Maxillofac Implants 12 (1997) 785-792
65. Kirker-Head C.A., Nevins M., Palmer R., et al. A new animal model for maxillary sinus floor augmentation: evaluation parameters. Int J Oral Maxillofac Implants 12 (1997) 403-411
66. Ludwig A., Gruber R., Nitsch A., et al. GDF-5 coated beta-TCP in sinus augmentation in minipigs. Int J Oral Maxillofac Surg 32 (2003) S1:55
67. Margolin M.D., Cogan A.G., Taylor M., et al. Maxillary sinus augmentation in the non-human primate: a comparative radiographic and histologic study between recombinant human osteogenic protein-1 and natural bone mineral. J Periodontol 69 (1998) 911-919
68. McAllister B.S., Margolin M.D., Cogan A.G., et al. Residual lateral wall defects following sinus grafting with recombinant human osteogenic protein-1 or Bio-Oss in the chimpanzee. Int J Periodontics Restorative Dent 18 (1998) 227-239
69. Nevins M., Kirker-Head C.A., Nevins M., et al. Bone formation in the goat maxillary sinus induced by absorbable collagen sponge implants impregnated with recombinant human bone morphogenetic protein-2. Int J Periodontics Restorative Dent 16 (1996) 8-19
70. Roldan J.C., Jepsen S., Schmidt C., et al. Sinus floor augmentation with simultaneous placement of dental implants in the presence of platelet-rich plasma or recombinant human bone morphogenetic protein-7. Clin Oral Implants Res 15 (2004) 716-723
71. Terheyden H., Jepsen S., Möller B., et al. Sinus floor augmentation with simultaneous placement of dental implants using a combination of deproteinized bone xenografts and recombinant human osteogenic protein-1: a histometric study in miniature pigs. Clin Oral Implants Res 10 (1999) 510-521
72. Terheyden H., Jepsen S., Möller B., et al. [Sinus floor augmentation with simultaneous implant insertion using recombinant human osteogenic protein-1]. Laryngorhinootologie 80 (2001) 47-51 [in German]
73. van den Bergh J.P., ten Bruggenkate C.M., Groeneveld H.H., et al. Recombinant human bone morphogenetic protein-7 in maxillary sinus floor elevation surgery in 3 patients compared to autogenous bone grafts: A clinical pilot study. J Clin Periodontol 27 (2000) 627-636
74. Boyne P.J., and Shabahang S. An evaluation of bone induction delivery materials in conjunction with root-form implant placement. Int J Periodontics Restorative Dent 21 (2001) 333-343
75. Cochran D.L., Nummikoski P.V., Jones A.A., et al. Radiographic analysis of regenerated bone around endosseous implants in canine using recombinant human bone morphogenetic protein-2. Int J Oral Maxillofac Implants 12 (1997) 739-748
76. Cochran D.L., Schenk R., Buser D., et al. Recombinant human bone morphogenetic protein-2 stimulation of bone formation around endosseous dental implants. J Periodontol 70 (1999) 139-151
77. Cochran D.L., Jones A.A., Lilly L.C., et al. Evaluation of recombinant human bone morphogenetic protein-2 in oral applications including the use of endosseous implants: 3-year results of a pilot study in humans. J Periodontol 71 (2000) 1241-1257
78. Fiorellini J.P., Howell T.H., Cochran D., et al. Randomized study evaluating recombinant human bone morphogenetic protein-2 for extraction socket augmentation. J Periodontol 76 (2005) 605-613
79. Hanisch O., Tatakis D.N., Boskovic M.M., et al. Bone formation and reosseointegration in peri-implantitis defects following surgical implantation of rhBMP-2. Int J Oral Maxillofac Implants 12 (1997) 604-610
80. Hanisch O., Sorensen R.G., Kinoshita A., et al. Effect of recombinant human bone morphogenetic protein-2 in dehiscence defects with non-submerged immediate implants: an experimental study in Cynomolgus monkeys. J Periodontol 74 (2003) 648-657
81. Jovanovic S.A., Hunt D.R., Bernard G.W., et al. Long-term functional loading of dental implants in rhBMP-2 induced bone: a histologic study in the canine ridge augmentation model. Clin Oral Implants Res 14 (2003) 793-803
82. Seto I., Tachikawa N., Mori M., et al. Restoration of occlusal function using osseointegrated implants in the canine mandible reconstructed by rhBMP-2. Clin Oral Implants Res 13 (2002) 536-541
83. Sigurdsson T.J., Fu E., Tatakis D.N., et al. Bone morphogenetic protein-2 enhances peri-implant bone regeneration and osseointegration. Clin Oral Implants Res 8 (1997) 367-374
84. Sigurdsson T.J., Nguyen S., and Wikesjö U.M.E. Alveolar ridge augmentation with rhBMP-2 and bone to implant contact in induced bone. Int J Periodontics Restorative Dent 21 (2001) 461-473
85. Sykaras N., Triplett R.G., Nunn M.E., et al. Effect of recombinant human bone morphogenetic protein-2 on bone regeneration and osseointegration of dental implants. Clin Oral Implants Res 12 (2001) 339-349
86. Tatakis D.N., Koh A., Jin L., et al. Peri-implant bone regeneration using rhBMP-2/ACS in a canine model: a dose-response study. J Periodontal Res 37 (2002) 93-100
87. Wikesjö U.M.E., Sorensen R.G., Kinoshita A., et al. rhBMP-2/α-BSM® induces significant vertical alveolar ridge augmentation and dental implant osseointegration. Clin Implant Dent Relat Res 4 (2002) 173-181
88. Wikesjö U.M.E., Qahash M., Thomson R.C., et al. Space-providing expanded polytetrafluoroethylene devices define alveolar augmentation at dental implants induced by recombinant human bone morphogenetic protein-2. Clin Implant Dent Relat Res 5 (2003) 112-123
89. Wikesjö U.M.E., Qahash M., Thomson R.C., et al. rhBMP-2 significantly enhances guided bone regeneration. Clin Oral Implants Res 15 (2004) 194-204
90. Blumenthal N.M., Koh-Kunts G., Alves M.E.A.F., et al. Effect of surgical implantation of recombinant human bone morphogenetic protein-2 in a bioabsorbable collagen sponge or a calcium phosphate putty carrier in intrabony periodontal defects in the baboon. J Periodontol 73 (2002) 1494-1506
91. Choi S.-H., Kim C.-K., Cho K.-S., et al. Effect of recombinant human bone morphogenetic protein-2/absorbable collagen sponge (rhBMP-2/ACS) on healing in 3-wall intrabony defects in dogs. J Periodontol 73 (2002) 63-72
92. Giannobile W.V., Ryan S., Shih M.-S., et al. Recombinant human osteogenic protein-1 (OP-1) stimulates periodontal wound healing in class III furcation defects. J Periodontol 69 (1998) 129-137
93. Ishikawa I., Kinoshita A., Oda S., et al. Regenerative therapy in periodontal disease: histological observations after implantation of rhBMP-2 in the surgically created periodontal defects in adults dogs. Dent Jpn 31 (1994) 141-146
94. Kinoshita A., Oda S., Takahashi K., et al. Periodontal regeneration by application of recombinant human bone morphogenetic protein-2 to horizontal circumferential defects created by experimental periodontitis in beagle dogs. J Periodontol 68 (1997) 103-109
95. Ripamonti U., Heliotis M., Rueger D.C., et al. Induction of cementogenesis by recombinant human osteogenic protein-1 (hop-1/bmp-7) in the baboon (Papio ursinus): short communication. Arch Oral Biol 41 (1996) 121-126
96. Saito E., Saito A., and Kawanami M. Favorable healing following space creation in rhBMP-2-induced periodontal regeneration of horizontal circumferential defects in dogs with experimental periodontitis. J Periodontol 74 (2003) 1808-1815
97. Selvig K.A., Sorensen R.G., Wozney J.M., et al. Bone repair following recombinant human bone morphogenetic protein-2 stimulated periodontal regeneration. J Periodontol 73 (2002) 1020-1029
98. Sigurdsson T.J., Lee M.B., Kubota K., et al. Periodontal repair in dogs: recombinant human bone morphogenetic protein-2 significantly enhances periodontal regeneration. J Periodontol 66 (1995) 131-138
99. Sigurdsson T.J., Tatakis D.N., Lee M.B., et al. Periodontal regenerative potential of space-providing expanded polytetrafluoroethylene membranes and recombinant human bone morphogenetic proteins. J Periodontol 66 (1995) 511-521
100. Sigurdsson T.J., Nygaard L., Tatakis D.N., et al. Periodontal repair in dogs: evaluation of rhBMP-2 carriers. Int J Periodontics Restorative Dent 16 (1996) 524-537
101. Sorensen R.G., Polimeni G., Kinoshita A., et al. Effect of recombinant human bone morphogenetic protein-12 (rhBMP-12) on regeneration of periodontal attachment following tooth replantation in dogs: a pilot study. J Clin Periodontol 31 (2004) 654-661
102. Sorensen R.G., Wikesjö U.M.E., Kinoshita A., et al. Periodontal repair in dogs: evaluation of a bioresorbable calcium phosphate cement (Ceredex™) as a carrier for rhBMP-2. J Clin Periodontol 31 (2004) 796-804
103. Springer I.N., Acil Y., Spies C., et al. rhBMP-7 improves survival and eruption in a growing tooth avulsion trauma model. Bone 37 (2005) 570-577
104. Wikesjö U.M.E., Guglielmoni P.G., Promsudthi A., et al. Periodontal repair in dogs: effect of rhBMP-2 concentration on regeneration of alveolar bone and periodontal attachment. J Clin Periodontol 26 (1999) 392-400
105. Wikesjö U.M.E., Lim W.H., Thomson R.C., et al. Periodontal repair in dogs: evaluation of a bioresorbable space-providing macro-porous membrane with recombinant human bone morphogenetic protein-2. J Periodontol 74 (2003) 635-647
106. Wikesjö U.M.E., Xiropaidis A.V., Thomson R.C., et al. Periodontal repair in dogs: rhBMP-2 significantly enhances bone formation under provisions for guided tissue regeneration. J Clin Periodontol 30 (2003) 705-714
107. Wikesjö U.M.E., Xiropaidis A.V., Thomson R.C., et al. Periodontal repair in dogs: space-providing ePTFE devices increase rhBMP-2/ACS induced bone formation. J Clin Periodontol 30 (2003) 715-725
108. Wikesjö U.M.E., Sorensen R.G., Kinoshita A., et al. Periodontal repair in dogs: effect of recombinant human bone morphogenetic protein-12 (rhBMP-12) on regeneration of alveolar bone and periodontal attachment. J Clin Periodontol 31 (2004) 662-670
109. Yamazaki Y., Oida S., Akimoto Y., et al. Response of the mouse femoral muscle to an implant of a composite of bone morphogenetic protein and plaster of Paris. Clin Orthop Relat Res 234 (1988) 240-249
110. Cole B.J., Bostrom M.P., Pritchard T.L., et al. Use of bone morphogenetic protein 2 on ectopic porous coated implants in the rat. Clin Orthop Relat Res 345 (1997) 219-228
111. Esenwein S.A., Esenwein S., Herr G., et al. [Osteogenetic activity of BMP-3-coated titanium specimens of different surface texture at the orthotopic implant bed of giant rabbits]. Chirurg 72 (2001) 1360-1368 [in German]
112. Hartwig C.-H., Esenwein S.A., Pfund A., et al. [Improved osseointegration of titanium implants of different surface characteristics by the use of bone morphogenetic protein (BMP-3): an animal study performed at the metaphyseal bone bed in dogs]. Z Orthop Ihre Grenzgeb 141 (2003) 705-711 [in German]
113. Herr G., Hartwig C.-H., Boll C., et al. Ectopic bone formation by composites of BMP and metal implants in rats. Acta Orthop Scand 67 (1996) 606-610
114. Kawai T., Mieki A., Ohno Y., et al. Osteoinductive activity of composites of bone morphogenetic protein and pure titanium. Clin Orthop Relat Res 290 (1993) 296-305
115. Schmidmaier G., Wildemann B., Cromme F., et al. Bone morphogenetic protein-2 coating of titanium implants increases biomechanical strength and accelerates bone remodeling in fracture treatment: a biomechanical and histological study in rats. Bone 30 (2002) 816-822
116. Vehof J.W., Mahmood J., Takita H., et al. Ectopic bone formation in titanium mesh loaded with bone morphogenetic protein and coated with calcium phosphate. Plast Reconstr Surg 108 (2001) 434-443
117. Hall J., Sorensen R.G., Wozney J.M., et al. Bone formation at rhBMP-2-coated titanium implants in the rat ectopic model. J Clin Periodontol 34 (2007) 444-451
118. Jin Q.M., Anusaksathien O., Webb S.A., et al. Gene therapy of bone morphogenetic protein for periodontal tissue engineering. J Periodontol 74 (2003) 202-213
119. Wikesjö U.M.E., Susin C., Qahash M., et al. The critical-size supraalveolar peri-implant defect model: characteristics and use. J Clin Periodontol 33 (2006) 846-854
120. Caplanis N., Sigurdsson T.J., Rohrer M.D., et al. Effect of allogeneic, freeze-dried, demineralized bone matrix on guided bone regeneration in supra-alveolar peri-implant defects in dogs. Int J Oral Maxillofac Implants 12 (1997) 634-642